Antimicrobial and Anti-Biofilm Activities of <i>Thymus fallax</i> Essential Oil against Oral Pathogens

Moshaverinia, Maryam; Sahmeddini, Sarina; Lavaee, Fatemeh; Zareshahrabadi, Zahra; Zomorodian, Kamiar

doi:https://doi.org/10.1155/2022/9744153

BioMed Research International

On this page

Abstract Introduction Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article Corrigendum

!

A Corrigendum for this article has been published. To view the article details, please click the ‘Corrigendum’ tab above.

Research Article | Open Access

Volume 2022 | Article ID 9744153 | https://doi.org/10.1155/2022/9744153

Antimicrobial and Anti-Biofilm Activities of Thymus fallax Essential Oil against Oral Pathogens

Maryam Moshaverinia,¹Sarina Sahmeddini,²Fatemeh Lavaee,³Zahra Zareshahrabadi,⁴and Kamiar Zomorodian^4,5

Academic Editor: Mingyun Li

Received25 Jun 2022

Revised21 Aug 2022

Accepted26 Aug 2022

Published12 Sept 2022

Abstract

Aim. Oral infections associated with a wide diversity of microorganisms, including bacteria and yeasts, occur frequently in humans, affecting the whole oral cavity and well-being. Oral pathogens easily grow and propagate in the oral cavity, leading to the formation of dental plaque on both soft and hard tissue. The oral cavity contains up to 700 different species of microorganisms, which Candida and Streptococci are the most common organisms. Oral diseases continue to increase despite the best efforts of the medical and scientific communities. During the past decades, drug resistance to common antibiotics used in the treatment of oral infections has been raised to high levels worldwide. To overcome such resistance, there is a growing tendency to use herbal medicine as alternative. This study was conducted to find out the chemical constitution of Thymus fallax (T. fallax) essential oil and to determine its antimicrobial and anti-biofilm efficacy against common oral pathogens. Materials and Methods. The chemical compositions of the essential oil distilled from T. fallax plants were analyzed using gas chromatography/mass spectrometry (GC/MS). Antimicrobial susceptibility testing against common Streptococcus, Enterococcus, Staphylococcus, and Candida strains was assessed by broth microdilution in 96-well plates as suggested by the Clinical and Laboratory Standards Institute (CLSI) methods. Biofilm growth and development were assessed using XTT reduction assay. Results. Based on the GC/MS test results, thymol (67.75%) followed by caryophyllene (E-) (7.27%) was the main component of this essential oil. T. fallax inhibited the growth of examined microbial pathogens at concentrations of 0.031-16 μL/mL. Also, the essential oil showed biofilm inhibition of greater than 95% in the concentration of 8 μL/mL against all tested bacterial strains as well as Candida albicans ( value < 0.05). Conclusions. Considering the significant antimicrobial activities of T. fallax, this essential oil has the potential to be used as further antimicrobial and anti-biofilm pharmaceutical products in the control and treatment of oral infections.

1. Introduction

Oral infections caused by microorganisms are one of the most common infections worldwide [1, 2]. It is now well known that oral infections can have different impacts on people’s well-being and life quality, causing pain, discomfort, and affecting proper physical functions [3, 4]. Besides, oral health is also associated with some sorts of systemic diseases such as diabetes, cardiovascular, and respiratory diseases [5]. Therefore, balancing the oral microflora and preventing the overgrowth of pathogens in the oral cavity is very important to improving oral health. Oral bacteria and Candida albicans are highly associated with oral diseases and infections, including dental caries, periodontitis, glossitis, and mucositis. Although some of them are normal flora of the oral cavity, growth and pathogenesis can be accelerated in patients with immune deficiencies [2, 6–8].

Currently, Streptococcus strains such as S. mutans and S. sobrinus are considered the most common bacteria isolated from dental plaque biofilms [9, 10]. Staphylococci are also abundant in dental implant and denture surfaces and supragingival and subgingival biofilm and plaque [11, 12] Staphylococcus contamination during implant surgery and its subsequent adhesion are still the primary causes of implant failure [11]. Enterococcus faecalis, another component of the oral microbiota, is mainly involved in failures of endodontic treatments, causing oral infections. Evaluation of Enterococcus faecalis biofilm formation by microtiter plate method presented 49% of the isolates as strong biofilm producer [13]. Uniquely, C. albicans is well adapted to humans’ oral cavity; however, any changes in the host environment provide this pathogen the opportunity to invade. Also, failure of antifungal therapies is very common in patients with denture stomatitis since its biofilm is very resistant [8].

For a long time, people used aromatic plants for their medicinal properties [14]. Numerous of these plants and their aromatic products have antimicrobial effects owing to their secondary metabolites like terpenoids [15]. A previous study also demonstrated the usage of essential oil (EO) in the treatment of oral infections [16]. Thymus spp., one of the main genera of the Lamiaceae family, have shown activity against bacteria and fungi. The EO of T. fallax also showed antibacterial activity against some other bacteria in the gastrointestinal tract [17].

Due to the high incidence of oral infections, increased resistance to common antibiotics, and the adverse effects of some chemical medications currently used in dentistry (e.g., nausea, diarrhea, vomiting, and tooth staining) [18], there is a great need for an alternative approach and novel compounds. Therefore, in this study, our aim is to investigate the in vitro antimicrobial and anti-biofilm efficacy of T. fallax EOs against oral pathogens.

2. Method and Material

2.1. T. fallax Extraction and Analyzation

T. fallax was harvested locally in the west of Iran and was air dried under proper conditions. Plant and voucher specimen were deposited in the herbarium of the Shiraz University of Medical Sciences. The aerial parts of the plant were powdered by an automatic blender and were hydrodistillated by all glass Clevenger type apparatus for 48 hours. Hydrous sodium sulfate was then added for dehumidification. The oil was restored in a sealed vial at a temperature of -20C until GC (gas chromatography) and GC-MS (gas chromatography-mass spectrometry) were done. Compounds were identified by comparing their mass spectra fragmentation pattern and retention time with standard reference compounds and comparing with retention times of n-alkanes (C₆-C₂₄) [19].

2.2. Microorganisms

Microorganisms were obtained from the Department of Microbiology, Shiraz University of Medical Sciences, Shiraz, Iran.

In this study, standard strains of Streptococcus mutans (ATCC35668), Streptococcus sanguinis (ATCC10556), Streptococcus salivarius (ATCC9222), Streptococcus sobrinus (ATCC27607), Staphylococcus aureus (ATCC52268), Enterococcus faecalis (ATCC51299), and Candida albicans (ATCC 10261) were used.

2.3. Determination of Minimum Inhibitory Concentration

The minimum inhibitory concentrations (MIC) were determined using the broth microdilution method; the inocula of bacteria and yeasts were prepared from 24-hour broth cultures. Suspensions were adjusted to 0.5 McFarland standard turbidity, that is, a stock suspension of cells/mL for bacteria and cells/mL for yeasts. For determination of antimicrobial activities against bacteria, serial dilutions of the EO (0.006 to 32.0 μL/mL) were prepared in Mueller-Hinton broth in 96-well microtiter plates, and for the yeast, serial dilutions of the EOs (0.006–32.0 μL/mL) were prepared in 96-well microtiter plates using RPMI-1640 media buffered with morpholinopropanesulfonic acid (MOPS). 0.1 mL of the working inoculums was added to the microtiter plates, and then, they were incubated in a humid atmosphere at 37°C for 24 hours (bacteria) or 30°C for 24–48 hours (yeast). 200 μL of the uninoculated medium was the sterility control (blank). Additionally, growth controls (medium with inoculums but without EO) were also included. The growth in each well was compared with the growth control well, and each test was performed in triplicate. MIC was visually determined as the lowest concentration of the EO, producing no visible growth. Furthermore, media from wells with no visible growth of bacteria on brain heart infusion agar (BHI) (Merck, Germany) were used to determine the minimum bactericidal concentration (MBC), and media from wells with no visible growth of fungi on Sabouraud dextrose agar (SDA) (Merck, Germany) were used to determine minimum fungicidal concentration (MFC). MBC and MFC were determined as the lowest concentrations yielding no more than 4 colonies that correspond to a mortality of 99.9% of the microbes in the initial inoculums [20].

2.4. Biofilm Preparation and Growth

Standard strains of bacteria were cultured on BHI and C. albicans was cultured on SDA. After 48 hours, one loop of the bacteria colonies was transferred to 20 mL of brain heart infusion broth, and one loop of the fungi colonies was transferred to 50 mL Erlenmeyer flasks containing 20 mL of Sabouraud dextrose broth (SDB) (Merck, Germany). They were incubated at 30°C on shaker at 100 rounds per minute for 24 hours. Then, the tested strains were washed twice in sterile phosphate-buffered saline (PBS) (0.8% [], NaCl 0.02% [], KH₂PO₄ 0.31% [], Na₂HPO₄+12H₂O 0.02% [], and KCl pH 7.4); then, washed cells were resuspended in Mueller-Hinton broth (bacteria) and in RPMI 1640 buffered with MOPS (yeasts). The cell densities were adjusted to cells/mL (bacteria) and cells/mL (yeasts) at a wavelength of 530 nm. Mueller-Hinton broth and RPMI 1640 were used to add serial dilutions of T. fallax (0.015 to 8 μL/mL) to 96-well plates. And then, the plates were incubated at 30°C for 48 hours. In addition, 200 μL of the uninoculated medium was used as a negative control (blank), and each of Mueller-Hinton broth and RPMI medias with the bacteria and yeasts but without the EO was considered as positive controls [1].

2.5. Assessing Biofilm Formation

Plates were washed with PBS again, and biofilm formation was assessed by using a 100 μL aliquot of XTT/Menadione. The plates were incubated at 37°C in a dark room for two hours. Finally, the colorimetric changes (optical density) were detected at OD₅₇₀ nm by using a microtiter plate reader. Then, the percentage of inhibition was compared with the positive controls.

2.6. Qualitative Observation of Biofilm Architecture by Fluorescent Microscopy

The morphological changes in C. albicans biofilms treated with T. fallax EO (0.015 μL/mL and 8 μL/mL) were studied using a fluorescent microscope (BX61, Olympus, Japan). After 48 h of incubation, unattached cells were removed by washing each well three times with PBS. For 30 minutes at room temperature, adhered cells were stained with calcofluor white 0.5% (which binds to polysaccharides to outline the yeast cell walls and produces brilliant fluorescence) and observed under a fluorescent microscope. Fluorescence images were taken at 488 and 530 nm for excitation and emission, respectively [21].

2.7. Statistics Analysis

Descriptive data were evaluated using means and standard deviations. One-way and two-way ANOVA were used to find out the variables using SPSS version 21. value of < 0.05 was considered to be statistically significant.

3. Results

3.1. GC-MS Investigation of T. fallax EO

The components of the pure EO were identified using GC/MS analyses (Figure 1). Based on the results, 20 different compounds were identified. Thymol was the predominant component (67.75%), followed by E-caryophyllene (7.27%). Table 1 tabulates the compounds of the T. fallax EO.

3.2. Antimicrobial Activity of T. fallax EO

The antibacterial activity of the EO against the examined bacteria was determined on the basis of MIC and MBC evaluation. T. fallax inhibited the growth of all of the examined strains at concentrations of 0.031-16 μL/mL. Throughout the study, S. salivarius had the lowest MICs and MBCs which were 0.031 μL/mL, while E. faecalis had the highest (0.125, 0.250 μL/mL). Table 2 presents the MIC and MBC/MFC values of the EO towards the studied bacterial and fungal species.

3.3. Biofilm Formation of Microorganisms

Biofilm growth and development were assessed using the XTT reduction assay. Based on the results, T. fallax EO showed biofilm inhibition of greater than 95% against all of the tested microbial strains at a concentration of 8 μL/mL. Indeed, T. fallax EO exhibited significant activity in the inhibition of biofilm formation as reflected by lower absorbance reading when compared with the untreated control. Moreover, at a concentration of 0.015 μL/mL, it had biofilm inhibition of more than 50% against S. mutans, S. salivarius, and S. aureus. It had the highest biofilm formation inhibitory effects ( value < 0.05) against S. sobrinus and S. salivarius (up to 99%) and the lowest inhibitory effects against S. sanguinis (Figure 2).

As is evident, fluorescence microscopy data further validate the XTT assay results. In the control group, fluorescence microscopy images revealed mature biofilm architecture with an abundance of fungal hyphae embedded within the extracellular matrix (Figures 3(a) and 3(b)). Following T. fallax EO treatment, the biofilm structure was destroyed, the extracellular matrix was reduced, mycelia were shortened, and only a small amount of biofilm remained (Figures 3(a) and 3(d)). These results confirmed that T. fallax EO significantly affected the biofilm structure of C. albicans.

(a)

(b)

(c)

(d)

4. Discussion

As mentioned, medicinal plants are now widely used due to their various properties. The genus Thymus L. is a member of the Lamiaceae family, a famous aromatic herb, which is widely grown in the Mediterranean region [22]. T. fallax is one of the 14 Thymus species in Iran, and its EO can be extracted from its leaves and flowering tops [23]. The major compounds detected in the GC/MS results were thymol (67.4%), caryophyllene (7.23%), and carvacrol (4.40%). These results were almost similar to other studies in Iran which were characterized by a high content of thymol (61.14-79.74%) [24–26]. In another investigation in Turkey, thymol with a lesser amount in comparison with the current study (41.48%) was the main constituent of the oil [27]. On the other hand, some other investigations in both Turkey and Iran showed that carvacrol was the principal component (66.1-69.2%) and thymol amounts were much lower in comparison with our results [17, 28, 29]. The EO content and the difference between GC/MS results may be affected by the time of harvest as well as environmental factors such as climate and soil condition. The EO successfully inhibited the growth of all tested bacteria and fungi. Even E. faecalis, which is naturally resistant to many antibiotics, was inhibited at MICs in 0.031-0.125 μL/mL range, which is lower than MICs of another Thymus species [29]. T. fontanesii, with similar major constituents (), inhibited the growth of S. aureus and C. albicans at the MIC of 1 μL/mL [30]. In comparison to other EOs, the MIC of T. fallax was lower than other EOs in the previous studies such as lavender, thyme, peppermint, and saliva (1-64 μL/mL) [31–33]. Generally, T. fallax showed strong antibacterial activity in comparison with others [30–34]. These differences might be due to various amounts of monoterpenes and the purity of EO.

Similarly, Küçükbay et al. studied the antimicrobial activities of T. fallax EO by the disc diffusion method and found moderate inhibitory activity against S. aureus and C. albicans. The lower inhibitory activities in their study in comparison to ours might be due to the different thymol/carvacrol ratio [17]. In another experiment using the disk diffusion test by Ozturk and Ercisli, T. fallax had considerable antibacterial activity against other bacteria at a concentration of 31.25-500 μg/mL [35].

Thymol is an oxygenated monoterpene, which its phenolic part can dissolve through the bacterial cell membrane and mitochondria and then interfere with their normal arrangement and metabolic mechanisms [36]. The mentioned mode of action is similar to the chlorhexidine antibacterial mechanism. Nevertheless, the antibacterial activity of T. fallax is not just due to one specific mechanism or compound, and other mechanisms are also considered for its antibacterial activity. However, the above-mentioned mechanism is more approved. Carvacrol, another component of the EO, is very similar to thymol functionally and structurally [37] E-Caryophyllene is also known for its anti-inflammatory and antibacterial properties [38].

Regarding the impact of the EO on the biofilm growth, which is shown in Figure 2, it can be noticed that the applied treatment caused a huge reduction in biofilm formation of the examined strains. The results showed that the effects of higher concentrations of EO led to a significantly greater cutback in biofilm growth. Based on the results, T. fallax showed a great anti-biofilm activity. Other studies on EOs containing thymol also suggested that this monoterpene can significantly reduce the biofilm formation by S. mutans, methicillin-resistant S. aureus, and E. faecalis [39–41]. Interestingly, Miladi et al. also noticed that thymol can synergistically increase the antibiotic effect of tetracycline against oral strains [40]. Dalleau et al.’s investigations about treatment of C. albicans biofilms with thymol (0.06%) resulted in more than 80% inhibition [42]. In another study by Kerekes et al.’s scanning electron microscopy was used to investigate the structural differences between S .aureus biofilms before and after treatment with thyme EO and thymol (0.1 mg/mL). After the treatment, the three-dimensional structure embedded in the extracellular polysaccharide layer appeared only in microcolonies with a simple shape, less attached cells, and more damaged [43]. So far, no other investigations have been done into the anti-biofilm activity of T. fallax against oral bacteria; therefore, the results were inevitably compared with other EOs with similar compounds. It is likely that the greater or lesser efficiency of EO’s contributes to the amount of composition and the time of exposure. In addition, it is noticeable that biofilms are well known for having considerable structural and physiological heterogeneity, even for those made by the same microorganisms under various environmental situations. In this study, both the anti-biofilm and antimicrobial activities of T. fallax against infectious oral bacteria and Candida were examined. Even though these effects were investigated on highly resistant and intracanal bacteria, we recommend using T. fallax EO as a mouth rinse or in vivo investigations in further studies to achieve more reliable results.

5. Conclusion

The current study revealed T. fallax possess considerable antimicrobial and anti-biofilm activities due to its major phenolic components, indicating that the EO is capable of preventing and interfering with microorganisms causing oral infections. Additionally, in addition to its antibacterial properties, it has a pleasant smell and flavor. T. fallax can be employed in oral hygiene products and may have a promising future in the treatment of oral bacteria.

Data Availability

The data used to support the findings of this study were supplied by the Shiraz University of Medical Sciences under license and so cannot be made freely available. Requests for access to these data should be made to Kamiar Zomorodian (zomorodian@sums.ac.ir or kzomorodian@gmail.com).

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Acknowledgments

The present article was extracted from the thesis of Sarina Sahmeddini and was financially supported by the Shiraz University of Medical Sciences (grant no. 22296).

References

M. Hejazi, Z. Zareshahrabadi, S. Ashayeri et al., “Characterization and physical and biological properties of tissue conditioner incorporated with Carum copticum L,” BioMed Research International, vol. 2021, Article ID 5577760, 10 pages, 2021.
View at: Publisher Site | Google Scholar
S. Rezaie, Z. Zareshahrabadi, K. Zomorodian et al., “Morphogenesis and pathogenesis regulation OF CANDIDA albicans BY probiotic bacterium–pediococcus acidilactici,” Journal of Microbiology, Biotechnology and Food Sciences, vol. 10, 2020.
View at: Publisher Site | Google Scholar
R. Baiju, “Oral health and quality of life: current concepts,” Journal of Clinical and Diagnostic Research: JCDR, vol. 11, no. 6, 2017.
View at: Publisher Site | Google Scholar
R. Giti, K. Zomorodian, M. Firouzmandi, Z. Zareshahrabadi, and S. Rahmannasab, “Antimicrobial activity of thermocycled polymethyl methacrylate resin reinforced with titanium dioxide and copper oxide nanoparticles,” International Journal of Dentistry, vol. 2021, Article ID 6690806, 8 pages, 2021.
View at: Publisher Site | Google Scholar
M. A. Nazir, “Prevalence of periodontal disease, its association with systemic diseases and prevention,” International Journal of Health Sciences, vol. 11, no. 2, pp. 72–80, 2017.
View at: Google Scholar
K. Krishnan, T. Chen, and B. Paster, “A practical guide to the oral microbiome and its relation to health and disease,” Oral Diseases, vol. 23, no. 3, pp. 276–286, 2017.
View at: Publisher Site | Google Scholar
M. McCormack, A. J. Smith, A. N. Akram, M. Jackson, D. Robertson, and G. Edwards, “Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection?” American Journal of Infection Control, vol. 43, no. 1, pp. 35–37, 2015.
View at: Publisher Site | Google Scholar
T. Vila, A. S. Sultan, D. Montelongo-Jauregui, and M. A. Jabra-Rizk, “Oral candidiasis: a disease of opportunity,” Journal of Fungi, vol. 6, no. 1, p. 15, 2020.
View at: Publisher Site | Google Scholar
S. Fragkou, C. Balasouli, O. Tsuzukibashi et al., “Streptococcus mutans, Streptococcus sobrinus and Candida albicans in oral samples from caries-free and caries-active children,” European Archives of Paediatric Dentistry, vol. 17, no. 5, pp. 367–375, 2016.
View at: Publisher Site | Google Scholar
E. Ansarifard, Z. Zareshahrabadi, N. Sarafraz, and K. Zomorodian, “Evaluation of antimicrobial and antibiofilm activities of copper oxide nanoparticles within soft denture liners against oral pathogens,” Bioinorganic Chemistry and Applications, vol. 2021, Article ID 9939275, 7 pages, 2021.
View at: Publisher Site | Google Scholar
J.-H. Lee, W. S. Jeong, S. J. Seo et al., “Non-thermal atmospheric pressure plasma functionalized dental implant for enhancement of bacterial resistance and osseointegration,” Dental Materials, vol. 33, no. 3, pp. 257–270, 2017.
View at: Publisher Site | Google Scholar
G. Koukos, D. Sakellari, M. Arsenakis, L. Tsalikis, T. Slini, and A. Konstantinidis, “Prevalence of Staphylococcus aureus and methicillin resistant Staphylococcus aureus (MRSA) in the oral cavity,” Archives of Oral Biology, vol. 60, no. 9, pp. 1410–1415, 2015.
View at: Publisher Site | Google Scholar
M. A. Aghdam, M. H. S. Barhaghi, M. Aghazadeh et al., “Virulence genes in biofilm producer enterococcus faecalis isolates from root canal infections,” Cellular and Molecular Biology, vol. 63, no. 5, pp. 55–59, 2017.
View at: Publisher Site | Google Scholar
S. M. Abdel-Aziz, A. Aeron, and T. A. Kahil, “Health benefits and possible risks of herbal medicine,” in Microbes in Food and Health, pp. 97–116, Springer, 2016.
View at: Publisher Site | Google Scholar
M. K. A. Baharudin, S. A. Hamid, and D. Susanti, “Chemical composition and antibacterial activity of essential oils from three aromatic plants of the Zingiberaceae family in Malaysia,” Journal of Physical Science, vol. 26, no. 1, 2015.
View at: Google Scholar
A. Merghni, H. Marzouki, H. Hentati, M. Aouni, and M. Mastouri, “Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections,” Current Research in Translational Medicine, vol. 64, no. 1, pp. 29–34, 2016.
View at: Publisher Site | Google Scholar
F. Z. Küçükbay, Chemical Composition of the Essential Oils of Three Thymus Taxa from Turkey with Antimicrobial and Antioxidant Activities, 2014.
B. Salehi, D. Kregiel, G. Mahady, J. Sharifi-Rad, N. Martins, and C. F. Rodrigues, “Management of Streptococcus mutans-Candida spp. oral biofilms’ infections: paving the way for effective clinical interventions,” Journal of Clinical Medicine, vol. 9, no. 2, p. 517, 2020.
View at: Publisher Site | Google Scholar
H. M. Hussein, “Determination of phytochemical composition and ten elements content (CD, CA, CR, CO, FE, PB, MG, MN, NI AND ZN) of Cardaria draba by GC-MS, FT-IR AND AAS techniques,” International Journal of Pharma and Bio Sciences, vol. 7, no. 3, pp. 1009–1017, 2016.
View at: Google Scholar
M. Bashiri, A. Jarrahpour, B. Rastegari et al., “Synthesis and evaluation of biological activities of tripodal imines and β-lactams attached to the 1, 3, 5-triazine nucleus,” Monatshefte für Chemie-Chemical Monthly, vol. 151, no. 5, pp. 821–835, 2020.
View at: Publisher Site | Google Scholar
F. Bonvicini, F. Belluti, A. Bisi, S. Gobbi, I. Manet, and G. A. Gentilomi, “Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm,” Research in Microbiology, vol. 172, no. 6, article 103873, 2021.
View at: Publisher Site | Google Scholar
G. Nieto, “Biological activities of three essential oils of the Lamiaceae family,” Medicine, vol. 4, no. 3, p. 63, 2017.
View at: Publisher Site | Google Scholar
A. Ghasemi Pirbalouti, Z. Emami Bistghani, and F. Malekpoor, “An overview on genus thymus,” Journal of Herbal Drugs (An International Journal on Medicinal Herbs), vol. 6, no. 2, pp. 93–100, 2015.
View at: Google Scholar
M. Barazandeh, “Essential oil composition of Thymus fallax Fisch. et CA Mey. from Iran,” Journal of Essential Oil Research, vol. 16, no. 2, pp. 101-102, 2004.
View at: Publisher Site | Google Scholar
B. Tohidi, M. Rahimmalek, and A. Arzani, “Essential oil composition, total phenolic, flavonoid contents, and antioxidant activity of Thymus species collected from different regions of Iran,” Food Chemistry, vol. 220, pp. 153–161, 2017.
View at: Publisher Site | Google Scholar
Y. I. Dizajeyekan, A. R. Haghighi, and T. E. Gajoti, “Quantitative and qualitative study of Thymus fallax essential oil in two habitats of East Azarbaijan province of Iran,” Gazi University Journal of Science, vol. 29, no. 4, pp. 959–962, 2016.
View at: Google Scholar
M. Yilar, Y. Bayan, H. Aksit, A. Onaran, I. Kadioglu, and Y. Yanar, “Bioherbicidal effects of essential oils isolated from Thymus fallax F., Mentha dumetorum Schult. and Origanum vulgare L,” Asian Journal of Chemistry, vol. 25, no. 8, pp. 4807–4811, 2013.
View at: Publisher Site | Google Scholar
G. Tümen, B. Yildiz, N. Kirimer, M. Kürkçüoglu, and K. H. C. Baser, “Composition of the essential oil of Thymus fallax Fisch. Et Mey. from Turkey,” Journal of Essential Oil Research, vol. 11, no. 4, pp. 489-490, 1999.
View at: Publisher Site | Google Scholar
A. R. Rustaiee, F. Sefidkon, I. Saeedi, and M. Rasouli, “Aromatic profile of Thymus fallax Fisch. & CA Mey. essential oil growing wild in Iran,” Journal of Essential Oil Bearing Plants, vol. 14, no. 6, pp. 782–785, 2011.
View at: Publisher Site | Google Scholar
T. Dob, D. Dahmane, T. Benabdelkader, and C. Chelghoum, “Composition and antimicrobial activity of the essential oil of Thymus fontanesii,” Pharmaceutical Biology, vol. 44, no. 8, pp. 607–612, 2006.
View at: Publisher Site | Google Scholar
N. Thosar, S. Basak, R. N. Bahadure, and M. Rajurkar, “Antimicrobial efficacy of five essential oils against oral pathogens: an in vitro study,” European journal of dentistry, vol. 7, 2013.
View at: Publisher Site | Google Scholar
K. Zomorodian, P. Ghadiri, M. J. Saharkhiz et al., “Antimicrobial activity of seven essential oils from Iranian aromatic plants against common causes of oral infections,” Jundishapur journal of microbiology, vol. 8, no. 2, p. e17766, 2015.
View at: Publisher Site | Google Scholar
A. Sonboli, B. Babakhani, and A. R. Mehrabian, “Antimicrobial activity of six constituents of essential oil from salvia,” Zeitschrift für Naturforschung C, vol. 61, no. 3-4, pp. 160–164, 2006.
View at: Publisher Site | Google Scholar
K. Ács, V. L. Balázs, B. Kocsis, T. Bencsik, A. Böszörményi, and G. Horváth, “Antibacterial activity evaluation of selected essential oils in liquid and vapor phase on respiratory tract pathogens,” BMC Complementary and Alternative Medicine, vol. 18, no. 1, pp. 1–9, 2018.
View at: Publisher Site | Google Scholar
S. Ozturk and S. Ercisli, “Broad-spectrum antibacterial properties of Thymus fallax,” Pharmaceutical Biology, vol. 43, no. 7, pp. 609–613, 2005.
View at: Publisher Site | Google Scholar
E. L. de Souza, J. C. de Barros, C. E. V. de Oliveira, and M. L. da Conceição, “Influence of Origanum vulgare L. essential oil on enterotoxin production, membrane permeability and surface characteristics of Staphylococcus aureus,” International Journal of Food Microbiology, vol. 137, no. 2-3, pp. 308–311, 2010.
View at: Publisher Site | Google Scholar
R. Lambert, P. N. Skandamis, P. J. Coote, and G. J. E. Nychas, “A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol,” Journal of Applied Microbiology, vol. 91, no. 3, pp. 453–462, 2001.
View at: Publisher Site | Google Scholar
P. R. Freitas, A. C. J. de Araújo, C. R. dos Santos Barbosa et al., “Characterization and antibacterial activity of the essential oil obtained from the leaves of Baccharis coridifolia DC against multiresistant strains,” Microbial Pathogenesis, vol. 145, article 104223, 2020.
View at: Publisher Site | Google Scholar
S. T. Khan, M. Khan, J. Ahmad et al., “Thymol and carvacrol induce autolysis, stress, growth inhibition and reduce the biofilm formation by Streptococcus mutans,” AMB Express, vol. 7, no. 1, pp. 1–11, 2017.
View at: Publisher Site | Google Scholar
H. Miladi, T. Zmantar, B. Kouidhi et al., “Synergistic effect of eugenol, carvacrol, thymol, p-cymene and γ-terpinene on inhibition of drug resistance and biofilm formation of oral bacteria,” Microbial Pathogenesis, vol. 112, pp. 156–163, 2017.
View at: Publisher Site | Google Scholar
A. Valliammai, A. Selvaraj, P. Mathumitha, C. Aravindraja, and S. K. Pandian, “Polymeric antibiofilm coating comprising synergistic combination of citral and thymol prevents methicillin-resistant Staphylococcus aureus biofilm formation on titanium,” Materials Science and Engineering: C, vol. 121, article 111863, 2021.
View at: Publisher Site | Google Scholar
S. Dalleau, E. Cateau, T. Bergès, J. M. Berjeaud, and C. Imbert, “In vitro activity of terpenes against Candida biofilms,” International Journal of Antimicrobial Agents, vol. 31, no. 6, pp. 572–576, 2008.
View at: Publisher Site | Google Scholar
E. B. Kerekes, A. Vidács, M. Takó et al., “Anti-biofilm effect of selected essential oils and main components on mono- and polymicrobic bacterial cultures,” Microorganisms, vol. 7, no. 9, p. 345, 2019.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Maryam Moshaverinia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies